18th European Congress: Perspectives in Lung Cancer

The 18th European Congress: Perspectives in Lung Cancer on 3-4 March 2017 provides valuable information on new treatment algorithms, targeted drugs, diagnostics, better use of chemotherapy, and key clinical trials data for management of patients with lung cancer.

Knowing the most-up-to-date techniques and data for developing strategies to personalize therapies for your patients is essential for best practices. A significant amount of practice changing data that affects the optimal way to treat, manage and care for your patients with lung cancer has been presented recently. Guided by world-renowned lung cancer experts, Perspectives in Lung Cancer will not only provide a comprehensive overview of the most significant advances in lung cancer treatment, but will aid attendees in confirming their current practices and optimizing their patient care.

Nearly 250 physicians, nurses, and other healthcare professionals attend Perspectives in Lung Cancer annually. Past participants value the scope and depth of the information on disease biology, management, and research presented, and many return year after year for the newest updates.

Price:
Physician Discounted Rate: EUR 549,
Physician Early Rate: EUR 649,
Physician Regular Rate: EUR 749,
Nurse, Fellow, Residents, Student, and Trainee Discounted Rate: EUR 249,
Nurse, Fellow, Residents, Student, and Trainee Early Rate: EUR 299,
Nurse, Fellow, Residents, Student, and Trainee Regular Rate: EUR 349,
Pharmaceutical Industry: EUR 925

Category: Conferences | Science, Health and Medicine | CME (Continuing Medical Education)

Speakers: Scagliotti, Baas, Aerts, Crinò, Dziadziuszko, Fennell, Girard, Gosney, Irion, Novello, Pérol, Quoix, Vansteenkiste